Physician profile
Andrew Bauder
NPI 1720433428
$4,352.45
in general payments reported to CMS, 2019-2025
7 companies · $1,090 in 2025
The $1,090 reported for 2025 was more than what 77% of Surgery of The Hand (Plastic Surgery) providers received nationally (typical 2025 total: $312).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $258 · 2023: $2,427 · 2024: $578 · 2025: $1,090.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,551 · Travel and Lodging: $1,544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,550.66 |
| Travel and Lodging | $1,543.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $1,578.71 | 2023-2025 | Acumed, Acumed, Innate Implant |
| Axogen | $1,512.92 | 2023 | Axoguard Nerve Protector, Axoguard Nerve Connector, Avance Nerve Graft |
| Arthrex, INC. | $755.27 | 2022-2023 | |
| Polynovo North America LLC | $172.27 | 2024 | Novosorb Btm |
| Avita Medical Americas, LLC | $123.80 | 2025 | Recell, Cohealyx, Permeaderm |
| Organogenesis INC. | $112.06 | 2025 | Puraply Wound Matrix |
| Stryker Corporation | $97.42 | 2023 | T2 Alpha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Bauder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.